Evaluation of Plasminogen Activator Inhibitor-1 (PAI-1) Levels in Blood Serum and Follicular Fluid (Predictive Marker) and its Effect on Oocytes Maturity in Iraqi Infertile Females Undergoing ICSI Protocol
DOI:
https://doi.org/10.28969/IJEIR.v14.i1.r5.24Keywords:
Plasminogen Activator Inhibitor-1 PAI-1, ICSI protocol, BlastocystsAbstract
ABSTRACT
Background: Plasminogen Activator Inhibitor-1 was expression in serum and follicular fluid has a direct role in maturity of oocytes and successful pregnancy outcome, which plays a crucial role in regulating fibrinolysis during pregnancy period by blocks the action of other protein called plasminogen activators.
Objective: Assessment the Plasminogen Activator Inhibitor-1 level in blood serum and follicular fluid as predictive marker of pregnancy and its effected on oocytes maturity in Iraqi infertile females undergoing ICSI protocol.
Materials and Methods: This study included Sixty-nine infertile female with mean age was (33.03 ±5.97) years, attended to High Institute for Infertility Diagnosis and Assisted Reproductive Technologies, Al-Nahrain University (Baghdad / Iraq), they underwent ICSI program, during a period from October 2022 till February 2023. All infertile female has same inclusion and exclusion criteria. Also, every female was asked some information including age, duration of infertility, body mass index (kg/m²), type of infertility, causes of infertility and hormonal assay, virology assay, husband’s seminal fluid analysis, and ultrasonography picture.
All females undergone ovarian stimulation with antagonist protocol and received recombinant follicle stimulating hormone, at the cycle day two. The serum and follicular fluid was collected from each female at the day of oocyte retrieval, for PAI estimation using Elisa kit (Diagnostic/ USA).
The data were analyzed using Statistical Package for Social Sciences (SPSS) version 23.0 and Microsoft office 2010.
Results: The results showed that serum PAI-1 levels at the day of oocytes retrievals were significantly lower in positive pregnancy women comparison with non-pregnant women (p < 0.05); Yet no significant follicular fluid PAI-1 levels were noted in comparison with non-pregnant women. There was a negative significant correlation (p > 0.05) of serum and follicular fluid PAI-1 levels at the day of oocytes retrieval according to oocytes ICSI outcome.
Conclusions: The results of present study concluded that evaluation of serum PAI-1 levels can be used as a promising parameter for the prediction of pregnancy outcome between pregnant and non-pregnant females. It is assumed that pregnancy rate was affected by PAI-1level during ICSI cycles.
Keywords: Plasminogen Activator Inhibitor-1 PAI-1, ICSI protocol, Blastocysts.
Corresponding author: should be addressed (Email: [email protected]).
Downloads
References
References:
• Abbassi-Ghanavati, M, Greer, L G and Cunningham, F G 2009, 'Pregnancy and laboratory studies: a reference table for clinicians', Obstetrics & Gynecology, vol. 114, no. 6, pp. 1326-1331.
• Agersnap, I, Nissen, P H, and Hvas, A M 2022, 'The role of plasminogen activator inhibitor type 1 (PAI-1) in placenta-mediated pregnancy complications: a systematic review', In Seminars in Thrombosis and Hemostasis, vol. 48, no. 05, pp. 607-624.
• Cardona Barberán, A, Boel, A, Vanden Meerschaut, F, Stoop, D and Heindryckx, B (2020), 'Diagnosis and treatment of male infertility-related fertilization failure', Journal of clinical medicine, vol. 9, no. 12, p. 3899.
• Chen, H, Nie, S and Lu, M 2015, 'Association between Plasminogen Activator Inhibitor‐1 Gene Polymorphisms and Recurrent Pregnancy Loss: A Systematic Review and Meta‐Analysis', American Journal of Reproductive Immunology, vol. 73, no. 4, pp.292-300.
• Chimote, N M and Chimote, B (2022), 'P-695 Anti-muellerian Hormone (AMH) and Plasminogen Activator Inhibitor (PAI-1) are robust follicular-fluid (FF) biomarkers predictive of follicle maturity and oocyte quality in women undergoing IVF cycles', Human Reproduction, vol. 37(Supplement_1), pp. deac107-644.
• Hasan, N A, Abdulhameed, W A and Rahim, A I 2020, 'Correlation Among Obesity, Oocyte Characteristics, Embryo Characteristics and Maternal Plasma Folate Level in a Sample of Iraqi Women Undergoing Intracytoplasmic Sperm Injection (ICSI)', Iraqi Journal of Embryos and Infertility Researches, vol. 10, no. 1, pp.1-19.
• Mehta, B N, Nath, N and Chimote, N (2014), 'Periodicity in the levels of serum plasminogen activator inhibitor-1 is a robust prognostic factor for embryo implantation and clinical pregnancy in ongoing IVF cycles', Journal of Human Reproductive Sciences, vol.7, no. 3, p.198.
• Mosconi, L, Crescioli, G, Vannacci, A, & Ravaldi, C 2021, 'Communication of Diagnosis of Infertility: A Systematic Review', Frontiers in psychology, vol. 12, pp. 615699.
• Pihusch, M, Pihusch, V, & Holler, E (2005), 'Plasminogen activator inhibitor-1: a review Plasminogen-Aktivator-Inhibitor-1', eine, Übersicht. LaboratoriumsMedizin, vol. 29, no. 6, pp. 403-411.
• Raheem, F A, Mossa, HA, Abdulhamed, W A and Altamimi, L R 2019, 'Assessment of Oxidative Stress Changes in Serum and Follicular Fluid in Relevance to GnRH Rival Protocol in Iraqi Infertile Ladies Undergoing ICSI', European Journal of Medical and Health Sciences, vol. 1, no. 5.
• Raheem, F A, Mossa, HA, Abdulhamed, W A and Altamimi, L R 2019, 'Assessment of Oxidative Stress Changes in Serum and Follicular Fluid in Relevance to GnRH Rival Protocol in Iraqi Infertile Ladies Undergoing ICSI', European Journal of Medical and Health Sciences, vol. 1, no. 5.
• Silvestris, E, De Pergola, G, Rosania, R and Loverro, G 2018, 'Obesity as disruptor of the female fertility', Reproductive Biology and Endocrinology, vol. 16, pp. 1-13.
• Tjärnlund-Wolf, A, Brogren, H, Lo, EH and Wang, X 2012, 'Plasminogen activator inhibitor-1 and thrombotic cerebrovascular diseases', Stroke, vol. 43, no.10, pp. 2833-2839.
• Van Heertum, K and Rossi, B 2017, 'Alcohol and fertility: how much is too much?', Fertility research and practice, vol. 3, no.1, pp.1-7.
• World Health Organization 2022, 'World Health Organization classification of anovulation and /or its affiliates, All Rights Reserved. Graphic 69734 Version 5.0.
• Xingxing Zhang,Tianqi Wang, Jingyan Song, Jifeng Deng & Zhengao Sun 2020, 'Study on follicular fluid metabolomics components at different ages based on lipid metabolism', Reproductive Biology and Endocrinology, vol. 18, no. 42.
• Ye, Y, Vattai, A, Zhang, X, Zhu, J, Thaler, C J, Mahner, S, Jeschke, U and Von Schönfeldt, V 2017, ''Role of plasminogen activator inhibitor type 1 in pathologies of female reproductive diseases', International journal of molecular sciences, vol. 18, no. 8, p. 1651.
• Zhang, X, Gao, B and Xu, B 2020, 'Association between plasminogen activator inhibitor-1 (PAI-1) 4G/5G polymorphism and risk of Alzheimer's disease, metabolic syndrome, and female infertility: a meta-analysis', Medicine, vol. 99, no. 50.
Published
How to Cite
License
Copyright (c) 2024 Samhar F. Alwan, Rana A. R. Alsaadi, Hayder A. L. Mossa
This work is licensed under a Creative Commons Attribution 4.0 International License.